Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Piedmont Reproductive Endocrinology Group (PREG) is a premier fertility center providing comprehensive reproductive health services in the Southeastern United States. Established in 2003, the organization specializes in advanced treatments including in vitro fertilization (IVF), intrauterine insemination (IUI), and third-party reproduction such as egg donation and gestational surrogacy. PREG operates several full-service clinics and state-of-the-art embryology laboratories across South Carolina and North Carolina. The group is recognized for its high success rates and personalized approach to treating conditions like polycystic ovary syndrome (PCOS) and endometriosis. In 2021, PREG joined the Pinnacle Fertility network, a leading physician-led fertility platform, to expand its clinical capabilities and resources. The practice remains dedicated to helping individuals and couples achieve their dreams of parenthood through cutting-edge technology and compassionate care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Piedmont Reproductive Endocrinology Group.